<DOC>
	<DOCNO>NCT00809172</DOCNO>
	<brief_summary>The systemic treatment moderate severe atopic dermatitis ( AD ) limit phototherapy cyclosporine risk respectively either carcinoma , hypertension nephropathy . Methotrexate effective 75 % moderate severe AD patient good tolerance open retrospective study . We want confirm observation : non inferiority multicenter clinical trial , methotrexate versus cyclosporine , conduct 100 patient 24 week .</brief_summary>
	<brief_title>Study Methotrexate Efficacy Versus Cyclosporine Moderate Severe Atopic Dermatitis Patients</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Patients age &gt; 18 year old . Both gender eligible study . Moderate severe AD . Scorad &gt; 15 . Participants must use contraceptive method trial 3 month end trial female 5 month male participant . Participants must able understand sign Informed Consent , comply aspect protocol . Patients must register social security system health insurance coverage . Pregnant lactating woman . Evolutive skin disease . Patients clinically significant disease ( chronic , recurrent active ) . Systemic corticotherapy immunosuppressive treatment previous month , local corticoid week inclusion . Contraindication methotrexate cyclosporine . Exposure phototherapy : cumulative dose &gt; 2000 J/cm2 . Patients deprive civic right , custody , subject tutorial , judiciary administrative decision . Patients protection measure . Patients critical medical situation . Patients personal situation evaluate investigator unable give optimal participation study , study could constitute risk patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Atopic-dermatitis</keyword>
	<keyword>scorad</keyword>
	<keyword>methotrexate</keyword>
	<keyword>ciclosporin</keyword>
</DOC>